AT17326U1 - A skin care composition in powder form from which a gel is made - Google Patents
A skin care composition in powder form from which a gel is made Download PDFInfo
- Publication number
- AT17326U1 AT17326U1 ATGM33/2021U AT332021U AT17326U1 AT 17326 U1 AT17326 U1 AT 17326U1 AT 332021 U AT332021 U AT 332021U AT 17326 U1 AT17326 U1 AT 17326U1
- Authority
- AT
- Austria
- Prior art keywords
- care composition
- skin care
- skin
- gel
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 239000000843 powder Substances 0.000 title claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000186660 Lactobacillus Species 0.000 claims abstract description 4
- 239000003349 gelling agent Substances 0.000 claims abstract description 4
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 4
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 3
- 150000004676 glycans Chemical class 0.000 claims abstract 4
- 229920001282 polysaccharide Polymers 0.000 claims abstract 4
- 239000005017 polysaccharide Substances 0.000 claims abstract 4
- 229930091371 Fructose Natural products 0.000 claims abstract 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract 3
- 239000005715 Fructose Substances 0.000 claims abstract 3
- 229920001202 Inulin Polymers 0.000 claims abstract 3
- 229920003086 cellulose ether Polymers 0.000 claims abstract 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract 3
- 229940029339 inulin Drugs 0.000 claims abstract 3
- 229920001285 xanthan gum Polymers 0.000 claims abstract 3
- 239000000230 xanthan gum Substances 0.000 claims abstract 3
- 229940082509 xanthan gum Drugs 0.000 claims abstract 3
- 235000010493 xanthan gum Nutrition 0.000 claims abstract 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 244000005714 skin microbiome Species 0.000 description 4
- 244000005700 microbiome Species 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 241000186679 Lactobacillus buchneri Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Die vorliegende Erfindung betrifft eine Hautpflegezusammensetzung in Pulverform, dadurch gekennzeichnet, dass diese Zusammensetzung hautfreundliche Bakterien wie Lactobacillus, Bifidobacterium und Streptococcus thermophilus, eine Mischung aus Polysacchariden und Fructosebausteinen wie Inulin und einen Gelbildner wie Polysaccharid wie Xanthan Gum oder Celluloseether enthält die in Verbindung mit Wasser ein Gel erzeugen.The present invention relates to a skin care composition in powder form, characterized in that this composition contains skin-friendly bacteria such as Lactobacillus, Bifidobacterium and Streptococcus thermophilus, a mixture of polysaccharides and fructose building blocks such as inulin and a gelling agent such as a polysaccharide such as xanthan gum or cellulose ether which is combined with water generate gel.
Description
1 TITEL DER ERFINDUNG: 1 TITLE OF THE INVENTION:
[0001] Die vorliegende Erfindung betrifft eine Hautpflegezusammensetzung in Pulverform, aus welcher ein Gel hergestellt wird. The present invention relates to a skin care composition in powder form from which a gel is made.
2 BESCHREIBUNGSEINLEITUNG: 2 DESCRIPTION INTRODUCTION:
[0002] Die menschliche Haut übt als größtes Organ des Menschen zahlreiche lebenswichtige Funktionen aus. Mit ihrer Oberfläche von durchschnittlich etwa 2 m2 beim erwachsenen Menschen kommt ihr eine herausragende Rolle als Schutz- und Sinnesorgan zu. So schützt die Haut den menschlichen Organismus. Unsere Haut wiederum wird durch die Hautflora geschützt. As the largest human organ, the human skin performs numerous vital functions. With an average surface area of around 2 m2 in adult humans, it plays an outstanding role as a protective and sensory organ. This is how the skin protects the human organism. Our skin, in turn, is protected by the skin flora.
[0003] Die resistente Hautflora setzt sich dabei aus verschiedenen hautfreundlichen Bakterienspezies wie Milchsäurebakterien, Pilzen und Phagen zusammen, die das Wachstum von Schadkeimen, in Schach halten und somit eine wichtige Schutzfunktion ausüben. The resistant skin flora is made up of various skin-friendly bacterial species such as lactic acid bacteria, fungi and phages, which keep the growth of harmful germs in check and thus perform an important protective function.
3 STAND DER TECHNIK: 3 STATE OF THE ART:
[0004] Das Vorkommen von Milchsäurebakterien in der normalen Flora von Darm, Haut und Schleimhäuten bei Mensch und Tier, wie auch deren Beteiligung bei der Ausbildung und Aufrechterhaltung eines sogenannten Schutzschildes auf der Haut, ist bekannt. Dabei dient der natürliche Schutzmantel der Haut vor allem dazu, die Ansiedelung unerwünschter Mikroorganismen zu verhindern und somit einer Infektionsgefahr vorzubeugen (Georg Fuchs, Hans-Günter Schlegel, „Allgemeine Mikrobiologie", 8. Auflage, Thieme Verlag (2006), S. 354). The occurrence of lactic acid bacteria in the normal flora of the intestine, skin and mucous membranes in humans and animals, as well as their involvement in the formation and maintenance of a so-called protective shield on the skin is known. The natural protective layer of the skin serves above all to prevent unwanted microorganisms from settling and thus to prevent the risk of infection (Georg Fuchs, Hans-Günter Schlegel, "Allgemeine Mikrobiologie", 8th edition, Thieme Verlag (2006), p. 354) .
[0005] Milchsäurebakterien sowie Milchsäure werden in Medizinprodukten daher vor allem dazu eingesetzt, bei Störungen oder Verlust der oben genannten Schutzschildfunktion diese zu stabilisieren oder wiederherzustellen. Erreicht wird dies durch Erhöhen und Aufrechterhalten der Milchsäurekonzentration auf der damit behandelten Haut oder Schleimhaut, so dass der physiologische pH-Wert wieder hergestellt wird. Diesbezügliche Produkte sind beispielsweise Vaginalkapseln oder Vaginalzäpfchen, die Milchsäurebakterien und/oder Milchsäure enthalten. [0005] Lactic acid bacteria and lactic acid are therefore primarily used in medical products to stabilize or restore the protective shield function mentioned above in the event of disruptions or loss. This is achieved by increasing and maintaining the concentration of lactic acid on the treated skin or mucosa so that the physiological pH is restored. Products in this regard are, for example, vaginal capsules or vaginal suppositories that contain lactic acid bacteria and/or lactic acid.
[0006] Die EP 1995307 B1 offenbart Verfahren und Mittel zum Schutz der Haut vor krankheitserregenden Mikroorganismen. Im Speziellen werden Mikroorganismen der Spezies Lactobacillus buchneri und Lactobacillus delbrückii verwendet, um das Wachstum spezieller pathogener Mikroorganismen zu inhibieren ohne dabei das Wachstum von Staphylococcus epidermidis zu hemmen, die der resistenten Hautflora zugerechnet werden. [0006] EP 1995307 B1 discloses methods and agents for protecting the skin from pathogenic microorganisms. In particular, microorganisms of the species Lactobacillus buchneri and Lactobacillus delbrückii are used to inhibit the growth of specific pathogenic microorganisms without inhibiting the growth of Staphylococcus epidermidis, which are assigned to the resistant skin flora.
[0007] Die DE 102015218204 A1, EP 1722804 B1 und WO 2018/036882 offenbaren, wie Mikroorganismen für die Hautpflege verwendet werden können. DE 102015218204 A1, EP 1722804 B1 and WO 2018/036882 disclose how microorganisms can be used for skin care.
4 AUFGABE DER ERFINDUNG: 4 OBJECT OF THE INVENTION:
[0008] Dem Erfinder liegt somit die Aufgabe zugrunde, eine Möglichkeit zu finden, hautfreundliche Bakterien wie Lactobacillus, Bifidobacterium und Streptococcus thermophilus auf die Hautoberfläche zu bringen, um die Hautflora aufzubauen. Diese Zusammensetzung soll so gestaltet sein, dass diese Zusammensetzung eine lange Haltbarkeit hat und ungekühlt gelagert werden kann. Weiters ist die Zusammensetzung So zu wählen, dass eine Verkeimung verhindert wird. Die Zusammensetzung muss einfach auf die Haut aufzutragen sein. The object of the inventor is therefore to find a way of bringing skin-friendly bacteria such as Lactobacillus, Bifidobacterium and Streptococcus thermophilus to the surface of the skin in order to build up the skin flora. This composition should be designed in such a way that this composition has a long shelf life and can be stored without refrigeration. Furthermore, the composition should be selected in such a way that contamination is prevented. The composition must be easy to apply to the skin.
5 LÖSUNG DER GESTELLTEN AUFGABE: 5 SOLUTION OF THE TASK:
[0009] Die Aufgabe wird dadurch gelöst, dass die Bakterienzusammensetzung in gefriergetrockneter Form vorliegt und mit einem Gelbildner als Feststoff (Pulver) versetzt ist. Diese Zusammensetzung ist in einer Einwegverpackung abgefüllt. Durch die Einwegverpackung ist eine Verkeimungsgefahr minimiert, da nur jene Menge verwendet wird, welche für eine Anwendung benötigt wird. Der Anwender kann diese Verpackung öffnen und die pulverförmige Zusammensetzung mit Wasser vermengen, um ein Gel herzustellen. Dieses Gel kann als Maske auf die Hautoberfläche aufgetragen werden. The object is achieved in that the bacterial composition is in freeze-dried form and is mixed with a gelling agent as a solid (powder). This composition is filled in disposable packaging. The one-way packaging minimizes the risk of contamination, since only the amount required for one application is used. The user can open this package and mix the powdered composition with water to make a gel. This gel can be applied to the surface of the skin as a mask.
Claims (6)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATGM33/2021U AT17326U1 (en) | 2021-03-29 | 2021-03-29 | A skin care composition in powder form from which a gel is made |
| DE102022100255.1A DE102022100255A1 (en) | 2021-03-29 | 2022-01-06 | Skin care composition in powder form |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATGM33/2021U AT17326U1 (en) | 2021-03-29 | 2021-03-29 | A skin care composition in powder form from which a gel is made |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT17326U1 true AT17326U1 (en) | 2021-12-15 |
Family
ID=78951111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ATGM33/2021U AT17326U1 (en) | 2021-03-29 | 2021-03-29 | A skin care composition in powder form from which a gel is made |
Country Status (2)
| Country | Link |
|---|---|
| AT (1) | AT17326U1 (en) |
| DE (1) | DE102022100255A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060008453A1 (en) * | 2004-06-23 | 2006-01-12 | L'oreal | Methods and compositions for preventing and treating sensitive and dry skin |
| US20060171936A1 (en) * | 2004-10-04 | 2006-08-03 | L'oreal | Cosmetic and/or dermatological composition for sensitive skin |
| EP2842606A1 (en) * | 2013-08-26 | 2015-03-04 | PM-International AG | Cosmetic yoghurt mask set and method for producing a yoghurt mask |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7510734B2 (en) | 2004-03-04 | 2009-03-31 | E-L Management Corporation | Skin treatment method with Lactobacillus extract |
| EP1736537A1 (en) | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Methods and means for protecting the skin against pathogenic microorganisms |
| DE102015218204A1 (en) | 2015-09-22 | 2017-03-23 | Henkel Ag & Co. Kgaa | skin cosmetic |
| DE102017103850A1 (en) | 2016-08-24 | 2018-03-01 | Georg Fritzmeier Gmbh & Co. Kg | Skin care composition |
-
2021
- 2021-03-29 AT ATGM33/2021U patent/AT17326U1/en unknown
-
2022
- 2022-01-06 DE DE102022100255.1A patent/DE102022100255A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060008453A1 (en) * | 2004-06-23 | 2006-01-12 | L'oreal | Methods and compositions for preventing and treating sensitive and dry skin |
| US20060171936A1 (en) * | 2004-10-04 | 2006-08-03 | L'oreal | Cosmetic and/or dermatological composition for sensitive skin |
| EP2842606A1 (en) * | 2013-08-26 | 2015-03-04 | PM-International AG | Cosmetic yoghurt mask set and method for producing a yoghurt mask |
Also Published As
| Publication number | Publication date |
|---|---|
| DE102022100255A1 (en) | 2022-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009003991A1 (en) | Composition containing at least one nutritive, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex | |
| DE102006060953A1 (en) | Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate | |
| DE60116302T2 (en) | Method of treating seborrheic dermatitis | |
| DE69100314T2 (en) | Treatment of Clostridium difficile diarrhea and pseudomembrane colitis. | |
| EP4185113A1 (en) | Disinfecting, skin-tolerable, superfatting care agent for application to the skin | |
| DE102017005168A1 (en) | Preparation for use in the oral cavity | |
| DE2113215A1 (en) | Therapeutic compound | |
| DE102015218892A1 (en) | Application mixture for increasing the effect of antiseptics and / or disinfectants, application agent with the content of the application mixture and the use of this mixture | |
| DE69924741T2 (en) | USE OF A COMPOSITION FOR THE PRODUCTION OF A MEDICAMENT FOR PREVENTING AND TREATING PARODONTITIS | |
| DE60022689T2 (en) | PHARMACEUTICAL DISINFECTANTS CONTAINING USNIC ACID AND AN ESSENTIAL OIL | |
| AT17326U1 (en) | A skin care composition in powder form from which a gel is made | |
| Conrad et al. | In-vitro-Untersuchungen zur antibakteriellen Wirksamkeit einer Kombination aus Kapuzinerkressenkraut (Tropaeoli majoris herba) und Meerrettichwurzel (Armoraciae rusticanae radix) | |
| DE3443242A1 (en) | Glycyrrhizin and a medicament containing an active compound | |
| EP2386309B1 (en) | Bulbine frutescens gel | |
| WO2001014468A1 (en) | Alginate preparation and use of the same | |
| DE2607441A1 (en) | DEODORIZING AGENT | |
| EP2564861B1 (en) | Pharmaceutical formula for treating mastitis in mammals | |
| EP2542211B1 (en) | Antimicrobial oil-in-water emulsion containing quaternary ammonium compounds | |
| DE3541814A1 (en) | DISINFECTING DRY COMPOSITION | |
| DE102007003765A1 (en) | Pharmaceutical composition for the treatment of incontinence | |
| EP4248956A2 (en) | Pharmaceutical composition comprising cannabidiol | |
| WO2023280636A1 (en) | Skin-compatible, conditioning, protecting and wound-disinfecting agent for application to the skin | |
| HANISCH | Physiologische und schmerzfreie Behandlung von eingewachsenen und eingerollten Zehennägeln: ERGEBNISSE EINER MULTIZENTRISCHEN ANWENDUNGSBEOBACHTUNG MIT EINEM NEUEN NAGELKORREKTURSYSTEM. | |
| Vollhaber | Klinische Erfahrungen mit Amoxycillin bei der Behandlung chronischer Bronchitiden. | |
| Hoppe-Tichy et al. | Stabilität von Voriconazol-Konzentrat und Voriconazol-Infusionsbeuteln |